MHRA Drug Safety Alerts

This page holds the a document file with the MHRA Drugs Alerts which are published monthly. The latest version is linked in a news item each month but past issues can be assessed from the MHRA website.



 NameDescriptionLast Modified  
Alert Letters
0 Folders, 2 Media Files.
Alert letters: Department of Health Chief Medical Officer, MHRA
Archive Alerts
0 Folders, 8 Media Files.
2017 drug safety alerts
101 - Drug Safety update - May 2018.pdf Info on: Valproate medicines (Epilim▼, Depakote▼): Pregnancy Prevention Programme, Braltus (tiotropium): 15 Nov 2018 16:01:42
102 - Drug Safety update - June 2018.pdf Info on: Dolutegravir (Tivicay▼, Triumeq▼, Juluca▼) and Denosumab (Xgeva▼) 15 Nov 2018 16:01:42
103 - Drug Safety update - July 2018.pdf inc: Darunavir boosted with cobicistat, pMDI, Eltrombopag (Revolade), Parenteral amphotericin B, Medicines taken during pregnancy 15 Nov 2018 16:01:42
104 - Drug Safety update - August 2018.pdf inc: Esmya (ulipristal acetate), letters sent to healthcare professionals 15 Nov 2018 16:01:42
105 - Drug Safety update - September 2018.pdf inc: Valproate Pregnancy Prevention Programme,Xofigo▼(radium-223-dichloride),Daclizumab beta (Zinbryta▼)Nusinersen (Spinraza▼) 15 Nov 2018 16:01:42
106 - Drug Safety update - October 2018.pdf inc: Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement, Rivaroxaban (Xarelto▼) after transcatheter aortic valve replacement,Ponatinib (Iclusig▼),Transdermal fentanyl patches 15 Nov 2018 16:01:42
107 - Drug Safety update - November 2018.pdf inc: Hydrochlorothiazide,Systemic and inhaled fluoroquinolones,Sildenafil (Revatio and Viagra)& Support Yellow Card 15 Nov 2018 16:01:42


© Coventry & Warwickshire Area Prescribing Committee 2018
Supplied by Marika Solutions Site powered by GP Fusion
Back to top